Realistic weight-loss figures instead of hype

Spectacular before-and-after pictures circulate online, but for a serious classification it is worth looking at the study figures. In the large approval studies, people with obesity without diabetes lost over about 72 weeks, depending on dose, on average around 15 to 22 percent of their body weight. With the highest dose the average in one study was about 22.5 percent. These are impressive values, but they are averages over long periods and always in combination with a change of diet and more exercise.

Decisive is the word average. Some people lose clearly more, others clearly less, and some hardly respond. The course is slow and extends over many months, not over weeks. Anyone who expects a fast solution over a few weeks will be disappointed. In addition there is an often overlooked point: a part of the lost weight is not fat but muscle mass. Therefore sufficient protein and strength training during the treatment are important to preserve the muscles as much as possible. Preserving the muscle mass is important not only for the appearance but also for the metabolism and long-term health. Serious use means approaching the matter with realistic expectations and medical guidance. It is also helpful not to measure the success only by the number on the scales. Improvements in blood pressure, blood sugar and blood fats as well as easier movement in everyday life are also important successes that sometimes carry more weight than the pure body weight. Anyone who puts the focus solely on maximum kilograms easily loses sight of what it is actually about in terms of health.

Side effects named honestly

Where advertising emphasises the benefit, serious information also includes a look at the side effects. Most common are gastrointestinal complaints: nausea, vomiting, diarrhoea and constipation. They occur above all in the phase in which the dose is slowly increased and ease for many over time. Exactly for this reason the dose is increased step by step and not set high straight away. These complaints are mostly unpleasant but not dangerous. Important is to drink enough in this phase and to listen to the body. Often smaller, lower-fat meals and slow eating help to ease the nausea. If the complaints persist permanently or are very strong, this should be discussed medically, because sometimes the dose increase can be adjusted or slowed to improve the tolerability.

There are, however, also rarer, more serious risks one should know. These include an inflammation of the pancreas, which can show through strong, persistent abdominal pain, as well as gallbladder problems up to gallstones, which occur more frequently with rapid weight loss. In combination with insulin or certain other diabetes agents a hypoglycaemia can occur. With the GLP-1-based agents a theoretical risk for certain thyroid tumours is also discussed, which stems above all from animal experiments. All of this should be discussed medically before the start of therapy. The own medical history also plays a role, such as earlier problems with the pancreas or the gallbladder. An open account of all previous illnesses and all other agents taken helps the practice to assess the risk correctly and to shape the treatment safely.

Not a lifestyle agent: serious instead of hype

Tirzepatide is often advertised on the internet as an uncomplicated slimming injection for everyone. This portrayal does not do the matter justice. It is a prescription-only medicine with clearly defined areas of use: type 2 diabetes as well as obesity or overweight with weight-related accompanying diseases. For a few kilograms for purely cosmetic reasons it is not intended. A serious use requires a medical indication, careful guidance and realistic expectations. Obtaining it from unsafe internet sources or without a prescription is strongly advised against, because there counterfeits and health dangers threaten. Precisely the large demand has in recent years let a market for counterfeit products arise whose content is unknown and partly dangerous. A medical examination before the start of treatment serves not bureaucracy but ensures that the agent is suitable for you and that no contraindications are present.

A further important point concerns the time after the treatment. Tirzepatide works as long as it is used. If you stop it, appetite and hunger mostly return, and without lasting changes in diet and exercise a part of the weight is frequently regained. Therefore the agent is not a short-term trick but a building block of a longer-term strategy. This does not necessarily mean that one has to take it for life, but it makes clear how important the accompanying changes in diet, exercise and habits are. It is exactly these changes that can carry a part of the success beyond the treatment. The medicine often first creates the room to break old patterns. This room, however, wants to be actively used so that the success is lasting. With obesity or type 2 diabetes it can be an effective building block but only unfolds its strength in interplay with lifestyle changes and medical guidance. Anyone seeking a comparison with semaglutide should weigh benefit, tolerability and costs together with the practice.

brite App

Your weekly therapy under control

A weekly injection with a slowly rising dose requires some organisation. brite helps you manage your medicines, be reminded of the weekly use and get notes on possible interactions. This way you keep therapy and appointments in view in one place.

• Clear, digital medication plan
• Reminders for the weekly use
• Notes on possible interactions

Start for free now